retatrutide downsides Side Effects 2026 side effects retatrutide Understanding Retatrutide

Obesity affects over 40 percent of Americansbut only about 6 percent of the US population is on a GLP-1 drug of some kind

If nothing changes, increment slowly

Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (ozempic) therapy for diabetes mellitus and obesity: a systematic literature review

As a peptide-based injectable targeting GLP-1, GIP, and glucagon receptors simultaneously, retatrutide shares the same temperature sensitivity as approved agents such as semaglutide and tirzepatide

Counter to this attitude was the emergence of the body positivity movement in the 2010s that sought to promote self-acceptance, celebrate body shape diversity, and prioritize metabolic health, challenging the use of BMI or weight as sole indicators of health without considering the broader context (Gailey, 2022

While Zepbound isnt a replacement for every treatment plan, it offers an additional tool especially for patients struggling with weight and traditional therapies